Article Details

Ovid Therapeutics Expands Its Anti-Epileptic Franchise With AstraZeneca Licensing Pact

Retrieved on: 2022-01-03 16:17:03

Tags for this article:

Click the tags to see associated articles and topics

Ovid Therapeutics Expands Its Anti-Epileptic Franchise With AstraZeneca Licensing Pact. View article details on hiswai:

Excerpt

Ovid Therapeutics Inc (NASDAQ: OVID) has entered into an exclusive license agreement with AstraZeneca plc (NASDAQ: AZN) for a library of ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up